Clinical Trial Update: A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating elranatamab in combination with cyclophosphamide for people with multiple myeloma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Elranatamab (elranatamab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Multiple Myeloma | Phase 2 | Status: RECRUITING